Helus Pharma names Michael Halstead CEO
CYBN•Helus Pharma appointed Michael Halstead as CEO to lead late-stage development and commercialization.
1. Leadership appointments
Helus Pharma appointed Michael Halstead as chief executive officer. Suresh Durgam joined the board, and board member Mark Lawson was appointed independent chair.




